Role of YES1 signaling in tumor therapy resistance.

Zhou, Hai; Sun, Dantong; Tao, Junyan; Xu, Mingjin; Zhang, Xiaochun; Hou, Helei

Zhou, Hai; Sun, Dantong; Tao, Junyan; Xu, Mingjin; Zhang, Xiaochun; Hou, Helei.

Afiliação

Zhou H; Precision Medicine Center of Oncology The Affiliated Hospital of Qingdao University Qingdao Shandong China.
Sun D; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Tao J; Qingdao Sixth People's Hospital Qingdao Shandong China.
Xu M; Department of Radiation Oncology The Affiliated Hospital of Qingdao University Qingdao Shandong China.
Zhang X; Precision Medicine Center of Oncology The Affiliated Hospital of Qingdao University Qingdao Shandong China.
Hou H; Precision Medicine Center of Oncology The Affiliated Hospital of Qingdao University Qingdao Shandong China.

Cancer Innov ; 2(3): 210-218, 2023 Jun.

Article em En | MEDLINE | ID: mdl-38089407

Palavras-chave

EGFRTKIs; YES1amplified malignancies; chemotherapy resistance; molecular mechanisms

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Innov Ano de publicação: 2023 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google